KIDSNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
ORTHOPEDIATRICS CORP
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026
$22.03+0.08 (+0.36%)
Close on Oct 19, 2026
- Market cap
- $529.79M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
+$4.79 (+27.78%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Earnings
ORTHOPEDIATRICS CORP grew revenue 14.5% to $252.73M over the twelve months to Jun 30, 2026. Free cash flow was -$1.84M.
Revenue
$252.73M
+14.5% vs. a year earlier
Operating income
-$30.00M
TTM Q2 2026
Free cash flow
-$1.84M
TTM Q2 2026
EPS, diluted
-$1.68
TTM Q2 2026
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $529.79M
- P/E ratio
- –
- Price to sales
- 2.10
- Price to book
- 1.54
- Dividend yield
- –
- Free cash flow yield
- -0.35%
Fundamentals
- Revenue
- $252.73M
- Net income
- -$39.73M
- EPS, diluted
- -$1.68
- Free cash flow
- -$1.84M
- Book value per share
- $14.29
- Diluted shares
- 24M
Twelve years at a glance
Fiscal years 2014 to 2025 and trailing twelve months, USD
Revenue
$252.73M+14.5% YoY
Gross profit
$186.14M+17.9% YoY
Operating income
-$30.00M
Net income
-$39.73M
EPS, diluted
-$1.68
Free cash flow
-$1.84M
Reported periodTrailing twelve months